BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6684455)

  • 1. Pharmacological study of CDP-choline. Protection against toxicity in a model of experimental hypoxia.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1022-4. PubMed ID: 6684455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of survival time in experimental hypoxia by cytidine diphosphate choline.
    Hamdorf G; Cervós-Navarro J; Müller R
    Arzneimittelforschung; 1992 Apr; 42(4):421-4. PubMed ID: 1642665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral CDP-choline on experimental withdrawal syndrome.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1018-21. PubMed ID: 6684454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the protection of CDP-choline against nicotine intoxication.
    Grau T; Romero A; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1025-6. PubMed ID: 6684456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of orally applied cytidine diphosphate choline in mild and severe degrees of normobaric and normocapnic degrees of hypoxia of rats.
    Hamdorf G; Cervós-Navarro J
    Arzneimittelforschung; 1991 Dec; 41(12):1206-10. PubMed ID: 1815517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
    Saligaut C; Daoust M; Chadelaud M; Moore N; Chretien P; Boismare F
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):5-8. PubMed ID: 3990445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological study of oral CDP-choline. Interaction with oxotremorine on the parasympathetic system.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1026-9. PubMed ID: 6684457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic dyskinesia with CDP-choline.
    Arranz J; Ganoza C
    Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDP-choline: acute toxicity study.
    Grau T; Romero A; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1033-4. PubMed ID: 6684459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissimilar effects in acute toxicity studies of CDP-choline and choline.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1016-8. PubMed ID: 6684453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDP-choline: 6-month study on toxicity in dogs.
    Romero A; Grau T; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1038-42. PubMed ID: 6684461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of subacute toxicity of CDP-choline after 30 days of oral administration to rats.
    Romero A; Grau T; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1035-8. PubMed ID: 6684460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioactivity incorporation into different cerebral phospholipids after oral administration of 14C methyl CDP-choline.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1048-50. PubMed ID: 6684464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the effects of oral administration of CDP-choline on EEG changes and lethality induced by epidural compression in the anaesthetised cat.
    Algate DR; Beard DJ; Sacristán A; Ortiz JA; Davies JE
    Arzneimittelforschung; 1983; 33(7A):1013-6. PubMed ID: 6684452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases.
    Lozano Fernández R
    Arzneimittelforschung; 1983; 33(7A):1073-80. PubMed ID: 6684470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of methyl-14C CDP-choline by oral route.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1045-7. PubMed ID: 6684463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral CDP-choline on acrylamide-induced lesion.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1029-33. PubMed ID: 6684458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the effects of oral administration of CDP-choline on open-field behaviour under conditions of chronic hypoxia.
    Hamdorf G; Cervós-Navarro J
    Arzneimittelforschung; 1990 May; 40(5):519-22. PubMed ID: 2383294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alveolar surfactant and experimental diabetes (protective action of citicoline)].
    Iozzo A; Cardellino G; Dalmasso F; Garbagni R
    Arch Sci Med (Torino); 1978; 135(2):181-6. PubMed ID: 581158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline.
    Weiss GB
    Life Sci; 1995; 56(9):637-60. PubMed ID: 7869846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.